Mičová Kateřina M.Sc.

Mičová Kateřina M.Sc.'s picture
Phone: +420 585632177
Doctoral training
Significance of intracellular and plasma levels of new tyrosine kinase inhibitors
The thesis is focused on development of HPLC-MS/MS methods for determination of tyrosine kinase inhibitors imatinib, nilotinib and dasatinib used for the treatment of chronic myeloid leukemia, and also on relationship between imatinib plasma levels and treatment response.

Status:

Graduated 2009 - 2014

Publications (Impact Factor Journals):

Publications (Other Reviewed Journals):

  • [1]
    MIČOVÁ, K., D. FRIEDECKÝ, E. FABER a T. ADAM. Rutinní terapeutické monitorování tyrosinkinázových inhibitorů metodou LC-MS/MS. Klinická biochemie a metabolismus. 2012, 20(41), 222-225. ISSN 1210-7921.